DERMLITE DL4W recalled over labeling errors
- Recall date
- March 20, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- DermLite LLC recalls DERMLITE DL4W, REF: DL4W, Rx Only MD, CE
- Recall number
- Z-1506-2023
- FDA classification
- Class II
- Brand / firm
- DermLite LLC
- Sold / distributed
- Worldwide - US Nationwide distribution in the states of CA, AZ, TX, FL, NE, IA, MO, CO and the countries of Saudi Arabia, Australia, Spain.
Why it was recalled
Incorrect labeling; Package labeling contains a different serial number then the serial number on the product labeling.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
DERMLITE DL4W, REF: DL4W, Rx Only MD, CE
Get recall alerts
Free email alert whenever DermLite LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: DermLite LLC